Ohio Public Employees Retirement System (OPERS)’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,527
Closed -$40.8K 2023
2023
Q4
$40.8K Sell
1,527
-906
-37% -$37.5K ﹤0.01% 1612
2023
Q3
$147K Hold
2,433
﹤0.01% 1395
2023
Q2
$248K Buy
+2,433
New +$335K ﹤0.01% 1364
2022
Q2
Sell
-1,968
Closed -$861K 2047
2022
Q1
$861K Hold
1,968
﹤0.01% 1259
2021
Q4
$863K Hold
1,968
﹤0.01% 1270
2021
Q3
$1.09M Buy
+1,968
New +$987K ﹤0.01% 1230

Other funds holding TVRD

Ohio Public Employees Retirement System (OPERS)'s TVRD Position: Q1 2024 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Tvardi Therapeutics (TVRD) in Q1 2024, closing a stake of 1,527 shares — an estimated $40.8K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in TVRD in Q3 2021 and held it in 6 quarters. The position peaked at $1.09M in Q3 2021. 97 funds tracked by Wall St. Rank hold TVRD as of Q1 2024.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Tvardi Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 1,527 Tvardi Therapeutics shares in Q1 2024, an estimated $40.8K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Tvardi Therapeutics in Q3 2021 and held it in 6 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Tvardi Therapeutics position peaked at $1.09M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2024.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2024, filed 15 May 2024.